Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: High-grade gliomas are highly aggressive brain tumors, and precise target volume delineation is crucial for effective treatment. This study aimed to evaluate the concordance and discrepancy between biological tumor volume (BTV) delineated using union of [F]FAPI-42 and [C]methionine and conventional gross tumor volume (GTV) in gliomas.
Methods: Nineteen glioma patients were retrospectively enrolled, who underwent [F]FAPI-42 and [C]methionine PET/MRI before radiation therapy. The optimal [F]FAPI-42 threshold for delineation was determined from five predefined thresholds based on volumetric consistency. Target volumes, including BTV based on [F]FAPI-42 PET (BTV-FAPI), [C]methionine (BTV-MET), their union (BTV-UNION), GTV on contrast-enhanced T1-weighted MRI (GTV-ce-T1w), clinical target volume (CTV)-UNION, and CTV-ce-T1w were delineated, and geometric comparisons were made between BTV-FAPI and BTV-MET, BTV-UNION and GTV-ce-T1w, and CTV-UNION and CTV-ce-T1w. Dice Similarity Coefficient (DSC), Jaccard similarity coefficient (JSC), and overlap volumes (OV) parameters were calculated for comparison among the different target volumes.
Results: The 20% standardized uptake value maximum (SUVmax) threshold was chosen as the optimal value for [F]FAPI-42 delineation. No significant volume difference was found between BTV-FAPI and BTV-MET (12.64 vs. 9.67 cc; P = 0.562), with low DSC (0.28), JSC (0.17), and OV (0.39). BTV-UNION showed no significant volume difference compared to GTV-ce-T1w (18.41 vs. 8.67 cc; P = 0.073), but had higher OV (0.82) and moderate improvements in DSC (0.50) and JSC (0.33). CTV-UNION was significantly larger than CTV-ce-T1w (198.03 vs. 118.58 cc; P = 0.011), with significant increases in DSC (0.82), JSC (0.70), and OV (0.96).
Conclusion: The union of [C]methionine and [F]FAPI-42 PET for target delineation offers complementary value, enabling the identification of a broader tumor-infiltrated region compared to that delineated by ce-T1w MRI, with potential for reduced glioma recurrence risk.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00259-025-07483-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ultrahypofractionated radiotherapy in one or two sessions for localized prostate cancer: a review of the evidence and future perspectives.
Clin Transl Oncol
September 2025
Department of Radiation Oncology, Vithas La Milagrosa University Hospital, Madrid, 28010, Spain.
This narrative review analyzes current evidence comparing single-session and two-session approaches in Stereotactic Body Radiation Therapy (SBRT) and high-dose-rate (HDR) brachytherapy for localized prostate cancer. These ultra-hypofractionated strategies deliver high-precision ablative doses while minimizing exposure to normal tissues. SBRT regimens with fewer than five fractions show tumor control comparable to conventional treatments, offering reduced treatment burden and increased convenience.
View Article and Find Full Text PDFPhysician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT).
J Neurooncol
September 2025
Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.
Purpose: Patients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.
View Article and Find Full Text PDFClinical utility of comprehensive genomic profiling test for colorectal cancer: a single institution prospective observational study.
J Cancer Res Clin Oncol
September 2025
Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.
Purpose: Next-generation sequencing (NGS) has revolutionized cancer treatment by enabling comprehensive cancer genomic profiling (CGP) to guide genotype-directed therapies. While several prospective trials have demonstrated varying outcomes with CGP in patients with advanced solid tumors, its clinical utility in colorectal cancer (CRC) remains to be evaluated.
Methods: We conducted a prospective observational study of CGP in our hospital between September 2019 and March 2024.
Nephron-sparing surgery in bilateral Wilms tumors: Limitations of current criteria and impact of tumor size on renal morbidity.
J Pediatr Urol
August 2025
Hacettepe University Medical Faculty, Department of Pediatric Surgery, Ankara, Turkey.
Background: Patients with synchronous bilateral Wilms tumor (BWT) face challenges in balancing oncological control and nephron-sparing surgery (NSS). This study aimed to identify objective criteria for NSS in BWT by applying SIOP RTSG 2016 Umbrella Study criteria, the RENAL nephrometry scoring system, three-dimensional (3D) tumor volume measurements, and residual healthy kidney volume assessment.
Methods: A retrospective analysis was conducted on 14 patients with synchronous BWT.
Targeted hotspot profiling reveals a functionally relevant mutation in bladder cancer.
Urol Oncol
September 2025
Nutritional, Genes and Human Disease Laboratory, Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, Bangladesh. Electronic address:
Background: Understanding the mutational landscape is critical for elucidating the molecular mechanisms driving cancer progression. This study aimed to profile somatic mutations in bladder cancer patients (N=7) from Bangladesh to provide insights into the genetic alterations underlying this malignancy.
Methods: We performed targeted sequencing of 50 oncogenes and tumor suppressor genes using the Ion AmpliSeq Cancer Hotspot Panel v2 on tumor and matched blood samples from seven bladder cancer patients.